Double maintains 3 strategies that include PTGX - Protagonist Therapeutics, Inc.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
RDFN | 57.90% | $1.28B | +30.98% | 0.00% |
MLYS | 55.07% | $1.00B | +16.81% | 0.00% |
REGN | 31.63% | $63.16B | -39.57% | 0.00% |
KRYS | 30.88% | $3.77B | -20.42% | 0.00% |
MWA | 28.73% | $3.95B | +31.46% | 1.05% |
CRNX | 28.65% | $2.92B | -39.88% | 0.00% |
ACLX | 28.35% | $3.22B | +10.72% | 0.00% |
ALKS | 28.31% | $5.15B | +27.60% | 0.00% |
KYMR | 27.91% | $1.95B | -15.67% | 0.00% |
WSC | 27.44% | $5.39B | -25.37% | 0.24% |
CNR | 26.78% | $3.82B | -17.62% | 0.83% |
APGE | 26.51% | $2.42B | -24.39% | 0.00% |
COGT | 26.12% | $543.09M | -36.14% | 0.00% |
EMBC | 25.93% | $681.44M | -17.89% | 5.14% |
KLG | 25.85% | $1.55B | -16.04% | 3.59% |
TTC | 25.57% | $7.63B | -13.87% | 1.93% |
NVAX | 25.33% | $1.02B | -56.32% | 0.00% |
DCO | 25.21% | $1.01B | +17.06% | 0.00% |
ROIV | 25.17% | $7.68B | -5.70% | 0.00% |
RCKT | 25.02% | $724.54M | -71.26% | 0.00% |
Current Value
$44.351 Year Return
Current Value
$44.351 Year Return
Yahoo
We recently published a list of 10 Best Cancer Stocks to Invest in for Long-Term Gains. In this article, we are going to take a look at where Protagonist Therapeutics, Inc. (NASDAQ:PTGX) stands against other best cancer stocks to invest in for long-term gain. Surging Cancer Cases and Costs Drive Growth in the Global Oncology […]
Yahoo
Data from icotrokinra ICONIC-TOTAL show 66% of patients with scalp psoriasis and 77% with genital psoriasis achieved site-specific clear or almost clear skin at Week 16 Icotrokinra continues to demonstrate a standout combination of significant skin ...
Yahoo
Most readers would already be aware that Protagonist Therapeutics' (NASDAQ:PTGX) stock increased significantly by 14...
Yahoo
Protagonist Therapeutics (PTGX) delivered earnings and revenue surprises of 62% and 149.90%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Yahoo
Positive top line results from rusfertide Phase 3 VERIFY trial in polycythemia vera (PV) announced; full data selected for oral presentation during plenary session at ASCO on June 1st Conference call to be held June 2nd at 8AM EDT to discuss rusfertide ...
Finnhub
NEWARK, Calif. — NEWARK, Calif. — Protagonist Therapeutics Inc. on Tuesday reported a loss of $11.7 million in its first quarter. On a per-share basis, the Newark, California-based company...
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTC | 41.56% | $4.48B | 0.15% |
PBE | 35.09% | $214.12M | 0.58% |
XBI | 32.76% | $4.85B | 0.35% |
IBB | 29.24% | $5.22B | 0.45% |
BBH | 26.53% | $327.42M | 0.35% |
PTH | 26.06% | $96.56M | 0.6% |
XPH | 23.65% | $136.58M | 0.35% |
FBT | 22.46% | $994.71M | 0.56% |
DHS | 21.98% | $1.20B | 0.38% |
PINK | 21.30% | $131.52M | 0.5% |
FHLC | 21.30% | $2.42B | 0.084% |
RSPH | 21.16% | $754.08M | 0.4% |
IHE | 21.15% | $550.13M | 0.39% |
PEY | 21.15% | $1.13B | 0.53% |
FDL | 20.99% | $5.35B | 0.45% |
VHT | 20.62% | $14.92B | 0.09% |
SPYD | 20.60% | $6.76B | 0.07% |
GNOM | 20.37% | $40.65M | 0.5% |
SCHD | 20.15% | $68.33B | 0.06% |
HDV | 19.97% | $10.94B | 0.08% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CHIQ | -0.01% | $239.71M | 0.65% |
MEAR | -0.02% | $1.03B | 0.25% |
IBMN | -0.03% | $446.12M | 0.18% |
FLCH | -0.05% | $173.68M | 0.19% |
ETHV | -0.12% | $123.08M | 0% |
MAGS | 0.14% | $2.24B | 0.29% |
USCI | -0.16% | $230.94M | 1.07% |
GDX | -0.16% | $14.11B | 0.51% |
TPMN | 0.18% | $31.54M | 0.65% |
MCHI | -0.24% | $6.10B | 0.59% |
CPNJ | -0.27% | $27.56M | 0.69% |
IAU | 0.27% | $45.68B | 0.25% |
ETH | -0.29% | $1.13B | 0% |
BAR | 0.29% | $1.10B | 0.1749% |
TFLO | 0.29% | $7.06B | 0.15% |
ETHW | -0.30% | $250.22M | 0% |
MSOS | -0.30% | $354.62M | 0.77% |
CETH | -0.32% | $24.05M | 0% |
EZET | -0.32% | $34.72M | 0% |
CXSE | 0.33% | $414.69M | 0.32% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
RL | 0.01% | $16.62B | +62.02% | 1.23% |
DY | 0.01% | $5.53B | +30.25% | 0.00% |
AIFU | 0.02% | $9.85M | -95.03% | 0.00% |
NIU | 0.03% | $238.21M | +38.46% | 0.00% |
MNSO | 0.03% | $6.42B | -15.64% | 2.93% |
SEE | -0.05% | $4.67B | -18.53% | 2.51% |
HSBC | 0.05% | $207.40B | +32.37% | 5.64% |
EA | -0.06% | $37.51B | +15.80% | 0.51% |
AMCX | 0.06% | $288.43M | -59.77% | 0.00% |
CRVO | -0.06% | $75.19M | -64.53% | 0.00% |
NE | 0.07% | $3.87B | -48.81% | 7.78% |
SFM | -0.07% | $15.78B | +108.43% | 0.00% |
COIN | 0.07% | $62.26B | +22.73% | 0.00% |
ICHR | 0.07% | $647.60M | -50.17% | 0.00% |
CARV | 0.08% | $7.41M | -22.87% | 0.00% |
ITRN | 0.08% | $793.43M | +36.71% | 4.43% |
META | 0.09% | $1.62T | +36.06% | 0.32% |
DK | -0.09% | $1.13B | -33.14% | 6.84% |
CPRI | -0.09% | $2.18B | -48.85% | 0.00% |
TPB | 0.09% | $1.29B | +113.31% | 0.40% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -12.86% | $109.64M | 0.85% |
JMST | -9.72% | $3.65B | 0.18% |
XHLF | -6.94% | $1.46B | 0.03% |
DBMF | -6.11% | $1.19B | 0.85% |
FXC | -5.86% | $87.40M | 0.4% |
BILS | -5.60% | $3.96B | 0.1356% |
USL | -5.30% | $41.76M | 0.85% |
KMLM | -4.95% | $188.32M | 0.9% |
IBDQ | -4.78% | $3.08B | 0.1% |
UDN | -4.76% | $137.74M | 0.78% |
FXE | -4.55% | $525.40M | 0.4% |
FXY | -4.38% | $838.61M | 0.4% |
TAIL | -4.34% | $140.49M | 0.59% |
BTAL | -4.17% | $361.41M | 1.43% |
DBO | -3.94% | $182.54M | 0.77% |
BNO | -3.92% | $86.13M | 1% |
HIGH | -3.90% | $188.11M | 0.52% |
FBY | -3.73% | $160.70M | 1.06% |
OILK | -3.59% | $63.21M | 0.69% |
HYDR | -3.51% | $26.84M | 0.5% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
NPWR | -28.40% | $125.92M | -85.93% | 0.00% |
STG | -16.45% | $27.05M | -37.35% | 0.00% |
FRPT | -15.83% | $4.06B | -34.87% | 0.00% |
RKT | -13.47% | $1.93B | -2.78% | 0.00% |
SRDX | -13.44% | $400.81M | -17.75% | 0.00% |
MEOH | -12.16% | $2.26B | -37.50% | 2.20% |
LFWD | -10.88% | $13.71M | -74.51% | 0.00% |
AMBC | -10.80% | $366.78M | -56.23% | 0.00% |
RDDT | -9.91% | $20.96B | +101.47% | 0.00% |
FAT | -9.89% | $47.94M | -11.25% | 10.49% |
TRMD | -9.81% | $1.74B | -53.07% | 28.35% |
BTCT | -9.27% | $25.35M | +93.08% | 0.00% |
DHT | -9.22% | $1.86B | -8.39% | 8.10% |
FRO | -9.19% | $4.02B | -33.86% | 9.65% |
ASTS | -9.16% | $6.27B | +551.12% | 0.00% |
NEXA | -8.94% | $701.93M | -27.40% | 0.00% |
GMAB | -8.76% | $12.08B | -33.73% | 0.00% |
VHC | -8.62% | $34.69M | +74.89% | 0.00% |
NVO | -8.44% | $222.67B | -50.28% | 2.61% |
CATO | -8.41% | $54.69M | -48.22% | 12.06% |